This mouse model mimics many features of HER2/neu+ breast cancer, including stochastic tumor onset, focal tumors arising near hyperplastic tissue, a long latency period, estrogen-dependent tumor development, and metastatic progression to the lungs [16–18]. This evidence concerns the gene ERBB2 and breast carcinoma.